We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s FY 2025 User Fee Schedules Notch Increases of Up to 44 Percent
FDA’s FY 2025 User Fee Schedules Notch Increases of Up to 44 Percent
The FDA has posted six user fee schedules for FY 2025 on the Federal Register showing increases of up to 44 percent — the highest being for biosimilars.
